文献
J-GLOBAL ID:201802226963245868
整理番号:18A1005048
全身性リウマチ疾患患者におけるニューモシスチス肺炎の化学予防のためのスルファメトキサゾール-トリメトプリムの最適処方:非盲検無作為化対照試験からの結果【JST・京大機械翻訳】
Optimal regimens of sulfamethoxazole-trimethoprim for chemoprophylaxis of Pneumocystis pneumonia in patients with systemic rheumatic diseases: results from a non-blinded, randomized controlled trial
著者 (46件):
Utsunomiya Masako
(Department of Pharmacovigilance, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan)
,
Utsunomiya Masako
(Department of Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan)
,
Utsunomiya Masako
(Department of Rheumatology, Musashino Red Cross Hospital, Tokyo, Japan)
,
Dobashi Hiroaki
(Department of Internal Medicine, Division of Hematology, Rheumatology and Respiratory Medicine, Faculty of Medicine, Kagawa University, Kida-gun, Japan)
,
Odani Toshio
(Third Department of Internal Medicine, Obihiro-Kosei General Hospital, Obihiro, Japan)
,
Odani Toshio
(Department of Internal Medicine, Hokusei Hospital, Chitose, Japan)
,
Saito Kazuyoshi
(First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan)
,
Yokogawa Naoto
(Department of Rheumatic Diseases, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan)
,
Nagasaka Kenji
(Department of Pharmacovigilance, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan)
,
Nagasaka Kenji
(Department of Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan)
,
Nagasaka Kenji
(Department of Rheumatology, Ome Municipal General Hospital, Tokyo, Japan)
,
Takenaka Kenchi
(Department of Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan)
,
Takenaka Kenchi
(Department of Rheumatology, Ome Municipal General Hospital, Tokyo, Japan)
,
Soejima Makoto
(Department of Rheumatology, Ome Municipal General Hospital, Tokyo, Japan)
,
Soejima Makoto
(Department of Rheumatology, Soka Municipal Hospital, Soka, Japan)
,
Sugihara Takahiko
(Department of Medicine and Rheumatology, Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan)
,
Hagiyama Hiroyuki
(Department of Rheumatology, Yokohama City Minato Red Cross Hospital, Yokohama, Japan)
,
Hirata Shinya
(Department of Hematology, Rheumatology, and Infectious Disease, Kumamoto University Graduate School of Medicine, Kumamoto, Japan)
,
Matsui Kazuo
(Department of Rheumatology, Kameda Medical Center, Kamogawa, Japan)
,
Matsui Kazuo
(Department of Internal Medicine, Takikawa Municipal Hospital, Takikawa, Japan)
,
Nonomura Yoshinori
(Department of Rheumatology, Tokyo Kyosai Hospital, Tokyo, Japan)
,
Kondo Masahiro
(Department of Rheumatology, Faculty of Medicine, Shimane University, Izumo, Japan)
,
Suzuki Fumihito
(Department of Rheumatology, Soka Municipal Hospital, Soka, Japan)
,
Suzuki Fumihito
(Department of Rheumatology, JA Toride Medical Center, Toride, Japan)
,
Tomita Makoto
(Clinical Research Center, Medical Hospital of Tokyo Medical and Dental University, Tokyo, Japan)
,
Kihara Mari
(Department of Pharmacovigilance, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan)
,
Kihara Mari
(Department of Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan)
,
Yokoyama Waka
(Department of Pharmacovigilance, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan)
,
Yokoyama Waka
(Department of Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan)
,
Hirano Fumio
(Department of Pharmacovigilance, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan)
,
Hirano Fumio
(Department of Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan)
,
Yamazaki Hayato
(Department of Pharmacovigilance, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan)
,
Yamazaki Hayato
(Department of Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan)
,
Sakai Ryoko
(Department of Pharmacovigilance, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan)
,
Sakai Ryoko
(Department of Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan)
,
Sakai Ryoko
(Division of Epidemiology and Pharmacoepidemiology of Rheumatic Diseases, Institute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan)
,
Nanki Toshihiro
(Department of Pharmacovigilance, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan)
,
Nanki Toshihiro
(Department of Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan)
,
Nanki Toshihiro
(Division of Rheumatology, Department of Internal Medicine, Toho University School of Medicine, Tokyo, Japan)
,
Koike Ryuji
(Department of Pharmacovigilance, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan)
,
Koike Ryuji
(Department of Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan)
,
Kohsaka Hitoshi
(Department of Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan)
,
Miyasaka Nobuyuki
(Department of Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan)
,
Harigai Masayoshi
(Department of Pharmacovigilance, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan)
,
Harigai Masayoshi
(Department of Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan)
,
Harigai Masayoshi
(Division of Epidemiology and Pharmacoepidemiology of Rheumatic Diseases, Institute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan)
資料名:
Arthritis Research & Therapy (Web)
(Arthritis Research & Therapy (Web))
巻:
19
号:
1
ページ:
7
発行年:
2017年
JST資料番号:
U7412A
ISSN:
1478-6362
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
イギリス (GBR)
言語:
英語 (EN)